Frontlight ResearchEarly access
Heart failure trials in Hong Kong
5 of 10 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Hong Kong
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Hong Kong, Shatin, New Territories
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 4Taking peopleThe Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
- Where
- Hong Kong
- Age
- 12 years and over
- People
- 30
- Run by
- The University of Hong Kong
See details and how to joinNCT07482943 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Hong Kong
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseTaking peopleTelemonitoring to Optimize Medication Titration for Heart Failure: a Feasibility Study
- Where
- Hong Kong
- Age
- 19 years and over
- People
- 80
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07016815